10.04.2017
Fresenius Medical Care AG & Co. KGaA DE0005785802
DGAP-News: Fresenius Medical Care AG & Co. KGaA published form 20-F for the fiscal year 2016
DGAP-News: Fresenius Medical Care AG & Co. KGaA / Key word(s): Miscellaneous
Fresenius Medical Care AG & Co. KGaA published form 20-F for the fiscal year
2016
10.04.2017 / 09:46
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Bad Homburg, Germany -Fresenius Medical Care AG & Co. KGaA ("the company" or
"Fresenius Medical Care"), the world's largest provider of dialysis products
and services, announced that it has filed the annual report 2016 under form
20-F with the U.S. Securities and Exchange Commission (SEC). The report is
available at the company's website www.freseniusmedicalcare.com in the
"Investors" section as well as at the SEC's website, www.sec.gov.
A hard copy of Fresenius Medical Care's annual report on form 20-F including
the complete audited financial statements may be obtained from the company
free of charge upon request to the company's Investor Relations department
by email at [email protected].
Fresenius Medical Care is the world's largest provider of products and
services for individuals with renal diseases of which around 3 million
patients worldwide regularly undergo dialysis treatment. Through its network
of 3,624 dialysis clinics, Fresenius Medical Care provides dialysis
treatments for 308,471 patients around the globe. Fresenius Medical Care is
also the leading provider of dialysis products such as dialysis machines or
dialyzers. Along with the core business, the company focuses on expanding
the range of related medical services in the field of Care Coordination.
Fresenius Medical Care is listed on the Frankfurt Stock Exchange (FME) and
on the New York Stock Exchange (FMS).
For more information visit the Company's website at
www.freseniusmedicalcare.com.
Disclaimer
This release contains forward-looking statements that are subject to various
risks and uncertainties. Actual results could differ materially from those
described in these forward-looking statements due to certain factors,
including changes in business, economic and competitive conditions,
regulatory reforms, foreign exchange rate fluctuations, uncertainties in
litigation or investigative proceedings, and the availability of financing.
These and other risks and uncertainties are detailed in Fresenius Medical
Care AG & Co. KGaA's reports filed with the U.S. Securities and Exchange
Commission. Fresenius Medical Care AG & Co. KGaA does not undertake any
responsibility to update the forward-looking statements in this release.
---------------------------------------------------------------------------
10.04.2017 Dissemination of a Corporate News, transmitted by DGAP - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Archive at www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: Fresenius Medical Care AG & Co. KGaA
Else-Kröner-Straße 1
61352 Bad Homburg
Germany
Phone: +49 (0) 6172- 609 2525
Fax: +49 (0) 6172- 609 2301
E-mail: [email protected]
Internet: www.freseniusmedicalcare.com
ISIN: DE0005785802, ,
WKN: 578580, 578583
Indices: DAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated
Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover,
Munich, Stuttgart, Tradegate Exchange; NYSE
End of News DGAP News Service
---------------------------------------------------------------------------
563625 10.04.2017
|
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu
Fresenius Medical Care AG & Co. KGaA ISIN: DE0005785802 können Sie bei EQS abrufen
Medtech , 578580 , FME , XETR:FME